Orthofix reaches agreement “in principle” with SEC over Brazil FCPA allegations
Texas-based medical device company Orthofix has set aside US$6.1 million in anticipation of a settlement with the US Securities and Exchange Commission over allegations of improper payments at its Brazilian subsidiary, Orthofix do Brasil.
To read more
Subscribe to Global Investigations Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Investigations Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10